Remodeling in small airways of asthma

Global initiative for asthma: global strategy for asthma management and prevention. Revised 2006. Azzawi, 1990, Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma, Am Rev Respir Dis, 142, 1407, 10.1164/ajrccm/142.6_Pt_1.1407 Leckie, 2000, Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response, Lancet, 356, 2144, 10.1016/S0140-6736(00)03496-6 Leckie, 2003, Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models, Am J Respir Med, 2, 245, 10.1007/BF03256653 Davies, 2003, Airway remodeling in asthma: new insights, J. Allerg Clin Immunol, 111, 215, 10.1067/mai.2003.128 Bentley, 2008, Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration, Proc Am Thorac Soc, 5, 89, 10.1513/pats.200705-063VS Bousquet, 1990, Eosinophilic inflammation in asthma, N Engl J Med, 323, 1033, 10.1056/NEJM199010113231505 Synek, 1996, Cellular infiltration of the airways in asthma of varying severity, Am J Respir Crit Care Med, 154, 224, 10.1164/ajrccm.154.1.8680684 Howarth, 1998, Small airway inflammation and asthma, Int J Clin Pract Suppl, 96, 15 Carroll, 1997, The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics, Eur Respir J, 10, 292, 10.1183/09031936.97.10020292 Hogg, 2004, Pathophysiology of airflow limitation in chronic obstructive pulmonary disease, Lancet, 364, 709, 10.1016/S0140-6736(04)16900-6 Martin, 2002, Therapeutic significance of distal airway inflammation in asthma, J Allerg Clin Immunol, 109, S447, 10.1067/mai.2002.121409 Tulic, 2001, Small airway inflammation in asthma, Respir Res, 2, 333, 10.1186/rr83 Haley, 1998, Inflammatory cell distribution within and along asthmatic airways, Am J Respir Crit Care Med, 158, 565, 10.1164/ajrccm.158.2.9705036 Faul, 1997, Lung immunopathology in cases of sudden asthma death, Eur Respir J, 10, 301, 10.1183/09031936.97.10020301 Hamid, 1997, Inflammation of small airways in asthma, J Allerg Clin Immunol, 100, 44, 10.1016/S0091-6749(97)70193-3 Wenzel, 1997, Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids, Am J Respir Crit Care Med, 156, 737, 10.1164/ajrccm.156.3.9610046 Vignola, 1998, Airway inflammation in mild intermittent and in persistent asthma, Am J Respir Crit Care Med, 157, 403, 10.1164/ajrccm.157.2.96-08040 Kraft, 1999, The distal airways: are they important in asthma?, Eur Respir J, 14, 1403, 10.1183/09031936.99.14614039 Carroll, 1997, The structure of large and small airways in nonfatal and fatal asthma, Am Rev Respir Dis, 147, 405, 10.1164/ajrccm/147.2.405 Saetta, 1991, Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma, Am Rev Respir Dis, 143, 138, 10.1164/ajrccm/143.1.138 Kuwano, 1993, Small airway dimensions in asthma and in chronic obstructive pulmonary disease, Am Rev Respir Dis, 148, 1220, 10.1164/ajrccm/148.5.1220 Bergeron, 2005, Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane–flunisolide, J Allerg Clin Immunol, 116, 983, 10.1016/j.jaci.2005.07.029 Ohrui, 1992, Partitioning of pulmonary responses to inhaled methacholine in subjects with asymptomatic asthma, Am Rev Respir Dis, 146, 1501, 10.1164/ajrccm/146.6.1501 Wagner, 1990, Peripheral lung resistance in normal and asthmatic subjects, Am Rev Respir Dis, 141, 584, 10.1164/ajrccm/141.3.584 Wiggs, 1992, A model of airway narrowing in asthma and in chronic obstructive pulmonary disease, Am Rev Respir Dis, 145, 1251, 10.1164/ajrccm/145.6.1251 Sly, 1996, Measurements of low frequency respiratory impedance in infants, Am J Respir Crit Care Med, 154, 161, 10.1164/ajrccm.154.1.8680673 Hall, 2001, Methacholine responsiveness in infants assessed with low frequency forced oscillation and forced expiration techniques, Thorax, 56, 42, 10.1136/thorax.56.1.42 James, 1989, The mechanics of airway narrowing in asthma, Am Rev Respir Dis, 139, 242, 10.1164/ajrccm/139.1.242 Wagner, 1998, Direct assessment of small airways reactivity in human subjects, Am J Respir Crit Care Med, 157, 447, 10.1164/ajrccm.157.2.9611043 Gelb, 1998, Pseudophysiologic emphysema resulting from severe small-airways disease, Am J Respir Crit Care Med, 158, 815, 10.1164/ajrccm.158.3.9801045 Awadh, 1998, Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning, Thorax, 53, 248, 10.1136/thx.53.4.248 Laurent, 2000, Functional significance of air trapping detected in moderate asthma, Eur Radiol, 10, 1404, 10.1007/s003300000504 Takizawa, 2001, Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD), Am J Respir Crit Care Med, 163, 1476, 10.1164/ajrccm.163.6.9908135 Leach, 1998, Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone, Eur Respir J, 12, 1346, 10.1183/09031936.98.12061346 Goldin, 1999, Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography, J Allerg Clin Immunol, 104, 258, 10.1016/S0091-6749(99)70043-6 Corren, 2001, Effective control of asthma with hydrofluoroalkane (HFA) flunisolide delivered as an extrafine aerosol in asthma patients, Ann Allerg Asthma Immunol, 87, 405, 10.1016/S1081-1206(10)62922-5 Busse, 1999, Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant, J Allerg Clin Immunol, 104, 1215, 10.1016/S0091-6749(99)70016-3 Cohen J, Rob Douma W, Ten Hacken NH, et al. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J 2008 [Epub ahead of print]. Borgstrom, 1994, Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects, Eur Respir J, 7, 69, 10.1183/09031936.94.07010069 Pizzichini, 1999, Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial, Eur Respir J, 14, 12, 10.1034/j.1399-3003.1999.14a04.x Muz, 2006, The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model, Exp Mol Med, 38, 109, 10.1038/emm.2006.14 Kelly, 2006, Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge, Chest, 130, 741, 10.1378/chest.130.3.741 Bjermer, 2007, Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation, J Allerg Clin Immunol, 120, 1269, 10.1016/j.jaci.2007.09.017 Takizawa, 2007, Novel strategies for the treatment of asthma, Recent Patents Inflammation Allerg Drug Discovery, 1, 13, 10.2174/187221307779815101